11,412
Participants
Start Date
January 1, 2000
Primary Completion Date
January 1, 2021
Study Completion Date
January 1, 2021
No intervention
Kidney recipients aged over 18 and of all sexes recruited from 2000 who have mGFR follow-up and clinical, biological, and immunological data
William J. von Liebig Centre for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester
Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb
Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Lyon
Department of Nephrology, Centre Hospitalier Universitaire, Montpellier, Montpellier
Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris
Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris
Kidney Transplant Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris, Paris
Nephrology, Dialysis and Renal Transplantation Department, Hôpital Nord, CHU de Saint-Etienne, Jean Monnet University, Université de Lyon, Saint-Etienne
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo
Paris Translational Research Center for Organ Transplantation
OTHER